Pernix Therapeutics Stock Price (NASDAQ:PTX)

Add to My Stocks
$0.91 $0.01 (1.09%) PTX stock closing price Sep 17, 2018 (Closing)
Prev Close* : $0.92
Market Cap:
$12.81M
Day Low: $0.86
52 Week Low: $0.79
Open: $0.89
Volume: -
Day High: $0.92
52 Week High: $3.35
Dividend:
0.00

Latest Stock Market News

Latest Articles

Pernix Therapeutics News - From Partners

Pernix Therapeutics Announces Sale of Non-Core Product   by Globe Newswire on Nov 06, 2017

PTX Stockcharts

View PTX PE ratio, PS ratio stocks charts and compare with peers.
PTX Chart
Note: Compare Pernix Therapeutics stock price history with the index and industry peers.

Pernix Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
0.08
PB ratio (
price to book ratio
)
-0.06

Pernix Therapeutics Returns

ROE
(return on equity)
-

Pernix Therapeutics Financial Ratios

Asset Turnover
0.49
Receivables Turnover
3.09
Debt to Equity
-
Dividend Yield
0%

PTX Industry Peers

Company Price Change (%)
Acasti Pharma (ACST)0.540 (0%)
Agile Therapeutics (AGRX)0.370.01 (2.78%)
Cumberland Pharma (CPIX)5.60.06 (1.08%)
Vanda Pharmaceuticals (VNDA)19.10.8 (4.02%)
Assertio Therap (ASRT)5.820.02 (0.34%)
Eli Lilly (LLY)105.710.06 (0.06%)
Durect (DRRX)1.110.03 (2.63%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Progenics Pharma (PGNX)5.880.27 (4.81%)
Teva Pharmaceutical (TEVA)23.430.58 (2.54%)
BAUSCH HEALTH (BHC)22.550.2 (0.89%)
Top gainers from Medical-Generic Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)19.862.02 (9.23%)
Supernus Pharma (SUPN)462.05 (4.27%)
Akorn (AKRX)13.290.44 (3.2%)
Mallinckrodt (MNK)29.670.83 (2.72%)
Corium (CORI)9.20.25 (2.65%)
Allergan (AGN)184.293.93 (2.09%)
Teligent (TLGT)3.690.05 (1.34%)
Top losers from Medical-Generic Drugs industry
* As of Sep 18, 2018

Pernix Therapeutics Holdings Inc Stock News - Partner Headlines

Pernix Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues146.06M140.85M175.85M121.74M84.87M
Net Income-77.14M-169.59M-148.31M-35.28M-25.63M
Total Operating Expense157.1M237.84M225.68M106.78M95.64M
View Pernix Therapeutics income statement
balance sheet20172016201520142013
Total Assets205.49M310.44M511.15M487.41M211.38M
Total Liabilities379.74M424.5M478.06M403.82M100.66M
Shareholders Equity-174.25M-114.06M33.09M83.59M110.72M
View Pernix Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-3.5M22.73M-4.23M10.48M21.84M
Net Cash from (used by) Operating Activities-5.93M-16.5M-14.74M8.89M-6.53M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.98M-1.21M-1.13M19.09M
View Pernix Therapeutics cash flow statement

Pernix Therapeutics Stock Message Board

Pernix Therapeutics stock lost 1.09%, and the last close price as of Sep 17, 2018 is $0.91 for PTX stock. Stock price or share price can be used to find the total market value of a company. Pernix Therapeutics market cap stands at $12.81M as of Sep 17, 2018. Pernix Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Pernix Therapeutics is worth a lot, it will most likely be reflected in an inflated Pernix Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Pernix Therapeutics stock quote data shows the number of shares traded. For Ex: 59,535 Pernix Therapeutics shares were traded as of last trading day, as seen from Pernix Therapeutics stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Pernix Therapeutics does not pay dividends. Pernix Therapeutics stock price history, gives the entire historical data for PTX stock.